Patent lawyers began breathing again Wednesday, as the specter of new patent rules was chased away, at least for a little while, by a Virginia court. A federal judge granted GlaxoSmithKline's motion for a preliminary injunction blocking the U.S. Patent and Trademark Office from implementing rules set to go into effect today. The new rules would reduce the number of claims, which help define a patent, and the number of continuations, which are used to amend patent claims and contest those that are rejected.
Patent Rules Put on Hold by Va. Judge
November 1, 2007
This article requires premium access
This article requires premium access to Law.com. Please sign in or subscribe to read the full text.